Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001759425-24-000038
Filing Date
2024-11-12
Accepted
2024-11-12 08:14:55
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20240930.htm   iXBRL 10-Q 1683489
2 EX-31.1 mirm-10qq324xexx311.htm EX-31.1 10576
3 EX-31.2 mirm-10qq324xexx312.htm EX-31.2 11465
4 EX-32.1 mirm-10qq324xexx321.htm EX-32.1 5153
5 EX-32.2 mirm-10qq324xexx322.htm EX-32.2 5869
  Complete submission text file 0001759425-24-000038.txt   7888048

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20240930.xsd EX-101.SCH 61783
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20240930_cal.xml EX-101.CAL 77380
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20240930_def.xml EX-101.DEF 284865
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20240930_lab.xml EX-101.LAB 633874
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20240930_pre.xml EX-101.PRE 454843
84 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20240930_htm.xml XML 1035950
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 241443634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)